Figure 6
From: NF-κB DNA-binding activity in embryos responding to a teratogen, cyclophosphamide
NF-κB complex formation in the liver and brain of E14 embryos exposed CP in combination with NaSAL.A: Nuclear extracts from the liver: 1 – no sample; 2 – E14, control; 3 – E14, 40 mg/kg CP+NaSAL; 4 – E14, 40 mg/kg CP; 5 – E14, NaSAL.B: Nuclear extracts from the brain: 1 – E14, 15 mg/kg CP; 2 – E14, 15 mg/kg CP + NaSAL; 3 – E14, control; 4 – E14, 40 mg/kg CP; 5 – no sample